全文获取类型
收费全文 | 3773篇 |
免费 | 182篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 310篇 |
妇产科学 | 30篇 |
基础医学 | 274篇 |
口腔科学 | 99篇 |
临床医学 | 282篇 |
内科学 | 768篇 |
皮肤病学 | 39篇 |
神经病学 | 220篇 |
特种医学 | 107篇 |
外科学 | 895篇 |
综合类 | 86篇 |
一般理论 | 2篇 |
预防医学 | 161篇 |
眼科学 | 131篇 |
药学 | 252篇 |
中国医学 | 9篇 |
肿瘤学 | 291篇 |
出版年
2024年 | 3篇 |
2023年 | 40篇 |
2022年 | 91篇 |
2021年 | 202篇 |
2020年 | 91篇 |
2019年 | 131篇 |
2018年 | 171篇 |
2017年 | 121篇 |
2016年 | 141篇 |
2015年 | 140篇 |
2014年 | 213篇 |
2013年 | 241篇 |
2012年 | 357篇 |
2011年 | 376篇 |
2010年 | 196篇 |
2009年 | 170篇 |
2008年 | 226篇 |
2007年 | 220篇 |
2006年 | 186篇 |
2005年 | 145篇 |
2004年 | 146篇 |
2003年 | 104篇 |
2002年 | 82篇 |
2001年 | 27篇 |
2000年 | 24篇 |
1999年 | 30篇 |
1998年 | 19篇 |
1997年 | 5篇 |
1996年 | 11篇 |
1995年 | 5篇 |
1994年 | 4篇 |
1993年 | 2篇 |
1992年 | 8篇 |
1991年 | 5篇 |
1990年 | 6篇 |
1989年 | 4篇 |
1986年 | 3篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1982年 | 1篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1974年 | 3篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1971年 | 3篇 |
1970年 | 1篇 |
1969年 | 2篇 |
1968年 | 5篇 |
1967年 | 4篇 |
排序方式: 共有3974条查询结果,搜索用时 15 毫秒
21.
22.
Depending upon various factors the surgical procedures in childhood are divided into three groups—immediate, intermediate
and elective. The timing of surgery is probably the most important factor governing the outcome of surgical correction in
pediatric surgery. With continuing research and clinical experience our understanding of the various conditions have improved
and with that has come a change in the optimum timing of many surgical procedures. This paper highlights the best timing of
surgery for some of the commoner pediatric surgical procedures and the reasons behind these so that the children may be referred
to pediatric surgeons in time. 相似文献
23.
Terry Y Shibuya Sanghun Kim Kevin Nguyen Johnny Do Christine E McLaren Kuo-Tung Li Wen-Pin Chen Parag Parikh Ashish Wadhwa Xiaolin Zi Vincent Y Chen Hau-Sin Wong William B Armstrong George H Yoo 《Clinical cancer research》2004,10(20):7088-7099
PURPOSE: We have proposed to characterize the mechanism through which bioactive surgical sutures generate a T(H)1 immune response and to define the immune-stimulating half-life of the sutures. EXPERIMENTAL DESIGN: Bioactive sutures of interferon gamma (IFNgamma), interleukin 2 (IL-2), anti-CD3/CD28, anti-CD3/CD28 + IL-2, or anti-CD3/CD28 + IFNgamma sutures were used to stimulate lymphocytes from normal donors and from head and neck cancer patients in vitro over a 24-day period. Cell supernatants were analyzed by ELISA, and T cells were phenotyped to characterize the immune response generated. Intracellular cytokine staining was performed to measure the expansion of flu-specific T cells. Electromobility shift assay and supershift assay were used to measure the intranuclear DNA binding activity of nuclear factor kappaB and its p65 subunit in T cells activated by sutures in the presence and absence of a proteasome inhibitor, MG-132. RESULTS: Anti-CD3/CD28, anti-CD3/CD28 + IL-2, or anti-CD3/CD28 + IFNgamma generated a prolonged T(H)1 immune response for 18 days in vitro. Anti-CD3/CD28 expanded flu-specific T cells. Activated T cells demonstrated enhanced CD40 ligand (CD40L) expression within 72 hours of stimulation, which stimulated other cells to secrete IL-12. Stimulated T cells demonstrated increased intranuclear expression of nuclear factor-kappaB, which was blocked by MG-132, and also reduced CD40L and IL-12 expression. CONCLUSIONS: This is the first report to demonstrate that bioactive surgical sutures can generate a prolonged T(H)1 immune response and expand flu-specific T cells. Bioactive sutures, which are primarily a T-cell stimulant, also stimulated other cells to secrete IL-12 and prolonged the immune response. Sutures may provide a novel in situ stimulating strategy for enhancing the immune system of cancer patients. 相似文献
24.
RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer. 总被引:21,自引:0,他引:21
Gerold Bepler Swati Sharma Alan Cantor Ashish Gautam Eric Haura George Simon Anupama Sharma Eric Sommers Lary Robinson 《Journal of clinical oncology》2004,22(10):1878-1885
PURPOSE: RRM1 has important functions in the determination of the malignant phenotype. It controls cell proliferation through deoxynucleotide production and metastatic propensity through PTEN induction. It is located in a region of loss of heterozygosity in non-small-cell lung cancer (NSCLC), which is a predictor of poor survival. We hypothesized that RRM1 expression would be a significant predictor of outcome in NSCLC. PATIENTS AND METHODS: A retrospective data set of 49 patients and a prospective data set of 77 patients with resectable NSCLC were studied. RNA was extracted from tumor and normal lung tissue, and expression of the genes RRM1, PTEN, and RRM2 was determined by real-time quantitative polymerase chain reaction. RESULTS: RRM1 expression was significantly correlated with PTEN and RRM2 expression in tumor tissue. RRM1 and PTEN expression in tumor tissue was highly predictive of overall (P =.011 and.018, respectively) and disease-free survival (P =.002 and.026, respectively). Patients with high levels of expression lived longer and had disease recurrence later than patients with low levels of RRM1 and PTEN. In a multivariate analysis, high RRM1 expression was predictive of long survival independent of tumor stage, performance status, and weight loss. CONCLUSION: RRM1 is a biologically and clinically important determinant of malignant behavior in NSCLC. Knowing the level of expression of this gene adds significant information to management decisions independent of the currently used outcome predictors of tumor stage, performance status, and weight loss. Future clinical trials should stratify patients based on expression of this gene to avoid unwanted biases. 相似文献
25.
Nuclear factor-kappaB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8. 总被引:5,自引:0,他引:5
Takashi Karashima Paul Sweeney Ashish Kamat Suyun Huang Sun J Kim Menashe Bar-Eli David J McConkey Colin P N Dinney 《Clinical cancer research》2003,9(7):2786-2797
PURPOSE: Interleukin (IL)-8 is an important mediator of angiogenesis, tumorigenicity, and metastasis in transitional cell carcinoma (TCC) of the bladder. Nuclear factor kappaB (NF-kappaB)/relA regulates IL-8 expression in several neoplasms. The purpose of this study was to determine whether the organ microenvironment (hypoxia, acidosis) regulates the expression of IL-8 in TCC via NF-kappaB, and whether inhibition of NF-kappaB function by mutant IkappaB-alpha prevents induction of IL-8 expression. EXPERIMENTAL DESIGN: IL-8 mRNA expression and protein production by human TCC cell lines (UM-UC-14, HTB-9, RT-4, KU-7 and 253J B-V) were measured by Northern blot analysis and ELISA under acidic (pH 7.35-6.0) and hypoxic (1.0% O(2)) conditions. The involvement of NF-kappaB and activator protein 1 in the regulation of IL-8 production was evaluated by electrophoretic mobility shift assay. Furthermore, the tumorigenicity and metastatic potential of UM-UC-14 cells were determined after transfection with mutant IkappaB-alpha. RESULTS: We found that acidic and hypoxic conditions increased IL-8 mRNA expression and protein production by several, but not all, TCC cell lines evaluated. NF-kappaB, but not activator protein 1, was inducibly activated in UM-UC-14 under both acidic and hypoxic conditions, but not in UM-UC-14 mutant IkappaB-alpha transfectants. Tumor growth and lymph node metastasis were inhibited in UM-UC-14 mutant IkappaB-alpha transfectants compared with UM-UC-14 controls. This effect was associated with the inhibition of IL-8 production, cellular proliferation, and angiogenesis. CONCLUSIONS: These results suggest that TCCs of the bladder have heterogenic responses to physicochemical changes in the microenvironment and identify NF-kappaB as a potential molecular target for therapy. 相似文献
26.
Percutaneous transluminal myocardial revascularisation presently appears to be a potential palliative treatment for coronary artery disease, neither controlled with drugs nor amenable to available coronary revascularisation techniques. Ongoing trials will provide answer to short and long term efficacy. Recent developments using angiogenic growth factors appear very promising, and the role of growth factors as an adjunct to percutaneous transmyocardial revascularisation with laser remains to be seen. 相似文献
27.
Background. Klippel-Feil syndrome (KFS) is characterised by congenital vertebral fusion of the cervical spine and a wide spectrum of
associated anomalies. KFS has often been considered a sporadic syndrome. However, since the publication of the original KFS
classification early this century, a number of KFS families have indicated heterogeneity complicated by a broad range of variable
expression. Objective. The two major objectives of this study were (1) to identify differences and similarities in the postnatal appearance, morphology,
position and inheritance of vertebral fusions within and between KFS families and (2) to establish a new KFS classification
focussed on KFS aetiology. Materials and methods. Vertebral fusions were assessed via spinal radiography. Chromosomal karyotypes were performed using routine cytogenetics.
Results. The medical histories of three KFS families are presented. The postnatal time, position and appearance of vertebral fusions,
associated anomalies and mode of inheritance were different for the three KFS families. Four classes of KFS are described
in a comprehensive classification table that allays much of the uncertainty arising from KFS heterogeneity and variable expression.
Conclusion. We have described four different KFS classes (KF1–4) within a comprehensive classification that addresses KFS genetic heterogeneity.
The position of vertebral fusions in the cervical spine and their incidence within affected families are delineating features
of KFS.
Received: 10 October 1997 Accepted: 20 April 1998 相似文献
28.
Sham L. Singla Yogender Singh Kadian Naveen Malhotra Ashish Goyal 《Indian journal of otolaryngology and head and neck surgery》2004,56(2):131-132
Neurilemmoma of the cervical sympathetic chain is a rare nerve tumour. Less than 40 confirmed cases have been reported in
the literature.1 2 Sometimes they can he mistaken as carotid body tumour but usual presentation of these lesions is an asymptomatic
neck mass. Because of the rarity of the tumour we report another case of neurilemmoma arising from cervical sympathetic chain
in a 19 years old male. 相似文献
29.
30.
Maen Abdelrahim Hadeel Al-Rawi Abdullah Esmail Jiaqiong Xu Godsfavour Umoru Fahad Ibnshamsah Ala Abudayyeh David Victor Ashish Saharia Robert McMillan Ebtesam Al Najjar Doaa Bugazia Maryam Al-Rawi Rafik M. Ghobrial 《Current oncology (Toronto, Ont.)》2022,29(5):3585
Background: The management of cholangiocarcinoma is continually reviewed on a current evidence basis to develop practice guidelines and consensus statements. However, the standardized treatment guidelines are still unclear for cholangiocarcinoma patients who are listed for liver transplantation. We aimed to validate and evaluate the potential efficacy of chemotherapy combination of Gemcitabine and Cisplatin as a neo-adjuvant treatment for cholangiocarcinoma patients before liver transplantation. Methods: In this prospective case series, patients with locally advanced, unresectable, hilar, or intrahepatic cholangiocarcinoma with no evidence of extrahepatic disease or vascular involvement were treated with a combination of neoadjuvant gemcitabine and cisplatin with no radiation. All patients included received chemotherapy prior to being listed for liver transplantation at a single cancer center according to an open-labeled, and center-approved clinical management protocol. The primary endpoints were the overall survival and recurrence-free survival after liver transplantation. Results: Between 1 March 2016, and 15 March 2022, 10 patients (8 males and 2 females) with a median age of 62.71(interquartile range: 60.02–71.87) had a confirmed diagnosis of intrahepatic or hilar cholangiocarcinoma and underwent liver transplantation. Median days of neoadjuvant therapy for a given combination of gemcitabine and cisplatin were 181 (IRQ: 120–250). Nine patients (90%) were reported with no recurrence or metastasis, and only 1 patient had confirmed metastasis (10%); days for metastasis after transplantation were 612 for this patient. All patients received a combination of gemcitabine and cisplatin as neo-adjuvant while awaiting liver transplantation. The median days of follow-up were 851 (813–967). Overall survival was 100% (95% CI 100–100%) at both years one and two; 75% (95% CI 13–96%) at years three to five. One patient died at eight hundred and eighty-five days. No adverse events were reported after liver transplantation including the patient who was confirmed with recurrence. Conclusions: Our finding demonstrated that neo-adjuvant gemcitabine and cisplatin with no radiation prior to liver transplantation resulted in excellent outcomes for patients with cholangiocarcinoma. 相似文献